- Home
- LBTYB vs PRCT Comparison
LBTYB vs PRCT Comparison
Compare LBTYB & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYB
- PRCT
- Stock Information
- Founded
- LBTYB 2004
- PRCT 2009
- Country
- LBTYB Bermuda
- PRCT United States
- Employees
- LBTYB N/A
- PRCT N/A
- Industry
- LBTYB Cable & Other Pay Television Services
- PRCT Medical Specialities
- Sector
- LBTYB Telecommunications
- PRCT Health Care
- Exchange
- LBTYB Nasdaq
- PRCT Nasdaq
- Market Cap
- LBTYB 4.0B
- PRCT 3.2B
- IPO Year
- LBTYB N/A
- PRCT 2021
- Fundamental
- Price
- LBTYB $12.00
- PRCT $56.03
- Analyst Decision
- LBTYB
- PRCT Strong Buy
- Analyst Count
- LBTYB 0
- PRCT 7
- Target Price
- LBTYB N/A
- PRCT $94.29
- AVG Volume (30 Days)
- LBTYB 306.0
- PRCT 1.1M
- Earning Date
- LBTYB 01-01-0001
- PRCT 04-30-2025
- Dividend Yield
- LBTYB N/A
- PRCT N/A
- EPS Growth
- LBTYB N/A
- PRCT N/A
- EPS
- LBTYB 4.23
- PRCT N/A
- Revenue
- LBTYB $4,341,900,000.00
- PRCT $224,498,000.00
- Revenue This Year
- LBTYB $2.03
- PRCT $46.28
- Revenue Next Year
- LBTYB N/A
- PRCT $32.67
- P/E Ratio
- LBTYB $2.55
- PRCT N/A
- Revenue Growth
- LBTYB 5.49
- PRCT 64.84
- 52 Week Low
- LBTYB $10.34
- PRCT $45.56
- 52 Week High
- LBTYB $21.90
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- LBTYB 62.19
- PRCT 34.53
- Support Level
- LBTYB $10.34
- PRCT $55.74
- Resistance Level
- LBTYB $12.22
- PRCT $62.90
- Average True Range (ATR)
- LBTYB 0.12
- PRCT 4.16
- MACD
- LBTYB 0.16
- PRCT -0.31
- Stochastic Oscillator
- LBTYB 88.30
- PRCT 5.68
About LBTYB Liberty Global Ltd. Class B
Liberty Global is a holding company with interests in several telecom companies in the UK, Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty is the owner of the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile-network-operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.